Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Alkermes Inc.
Sponsor

Alkermes Inc.

United States 900 Winter Street, 02451-1449, United States

About the sponsor

Alkermes Inc. is active in clinical research focused on narcolepsy and idiopathic hypersomnia, with studies addressing both narcolepsy type 1 and narcolepsy type 2.

  • Excessive daytime sleepiness
  • Wakefulness regulation
  • Idiopathic hypersomnia
  • Narcolepsy type 1
  • Narcolepsy type 2

The sponsor’s trial portfolio reflects a strong therapeutic interest in disorders that disrupt alertness, sleep continuity, and daytime functioning.

About Specializations

Alkermes Inc. runs clinical trials in conditions such as Narcolepsy, Hypersomnia, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

7 clinical trials

Narcolepsy

Recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Alks 2680
  • Sponsor:Alkermes Inc.

Narcolepsy

Recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Alks 2680
  • Sponsor:Alkermes Inc.

Narcolepsy+1

Recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Alks 2680
  • Sponsor:Alkermes Inc.

Hypersomnia

Not recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Alks 2680
  • Sponsor:Alkermes Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.